Selank research in Canada investigates the anxiolytic and nootropic properties of this synthetic heptapeptide. Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) is a synthetic analogue of the endogenous human tetrapeptide tuftsin (Thr-Lys-Pro-Arg) with an added Pro-Gly-Pro sequence that extends its stability and CNS activity. Developed by the Institute of Molecular Genetics of the Russian Academy of Sciences, selank is studied by Canadian neuroscience researchers for its effects on GABA receptor modulation, BDNF expression, serotonin metabolism, and HPA axis stress signalling.
GABA System and Anxiety Research
Selank is studied for its interaction with the GABA-A receptor system. Unlike classical benzodiazepines, selank appears to produce anxiolytic-like effects in animal models through GABA modulation without accompanying sedation or dependence in short-term research protocols. Canadian anxiety biology researchers use selank to investigate alternative peptide-based GABAergic signalling modulation.
BDNF and Cognitive Research
Selank is studied for its ability to increase BDNF (brain-derived neurotrophic factor) expression in the hippocampus in animal research models. Canadian neurotrophic factor researchers study selank alongside semax to investigate how synthetic regulatory peptides influence neurotrophic signalling as a mechanism for cognitive enhancement.
Sourcing Selank in Canada
Research-grade selank is available in Canada from EhBuddy Peptides in nasal and injectable forms. Lab-tested for purity. For laboratory research use only.
Selank is an important research peptide in Canada for scientists studying anxiolytic mechanisms, GABA neuropharmacology, and BDNF-driven neuroplasticity biology.
